Merck KGaA (MKGAY) Stock Price, News & Analysis

Company Overview

Merck KGaA, trading in the United States under the ticker OTCMKTS:MKGAY, is a German multinational pharmaceutical, chemical and life sciences company headquartered in Darmstadt, Germany. Founded in 1668, the company has grown into one of the world’s oldest and most diversified healthcare and science enterprises. Merck KGaA operates globally under three main business sectors—Healthcare, Life Science and Performance Materials—offering a comprehensive portfolio of prescription medicines, laboratory supplies, specialty chemicals and advanced materials.

In the Healthcare division, Merck KGaA focuses on oncology, immunology, fertility, neuroscience and endocrinology, developing innovative therapies and diagnostics for chronic and life-threatening diseases. The company’s pipeline includes targeted cancer treatments as well as products for autoimmune and neurological disorders. Merck KGaA’s Life Science arm, rebranded as MilliporeSigma in North America following the acquisition of Sigma-Aldrich in 2015, supplies research reagents, consumables, equipment and services to pharmaceutical, biotech and academic laboratories worldwide.

The Performance Materials segment produces specialty chemicals and high-performance materials for the electronics, display and automotive industries. This division is known for liquid crystals, OLED materials and precursors used in flat-panel displays, semiconductors and next-generation technologies. Merck KGaA also provides functional printing solutions and organometallic compounds that support innovation in packaging, coatings and energy applications.

With operations spanning more than 60 countries, Merck KGaA serves customers across Europe, the Americas, Asia and Africa. The company is led by Chairman and CEO Belén Garijo, who has held executive leadership roles since 2016 and oversees strategic initiatives in research, digital transformation and sustainability. Merck KGaA continues to invest in R&D and global partnerships to advance scientific progress and address unmet medical and technological needs.

Key Stats

• Today's Range: $38.36 to $38.36
• 50-Day Range: $38.36 to $38.36
• 52-Week Range: $32.53 to $42.02
• Volume: N/A
• Average Volume: 6,872 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

MKGAY Stock Analysis - Frequently Asked Questions

How have MKGAY shares performed this year?

Merck KGaA's stock was trading at $38.36 at the beginning of 2025. Since then, MKGAY shares have increased by 0.0% and is now trading at $38.36.

How do I buy shares of Merck KGaA?

Shares of MKGAY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Pharmaceuticals - Major
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:MKGAY
• CIK: N/A
• Web: N/A
• Phone: 496151720
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A